InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

- Current share price for ATH : $0.400

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$92 Date of AGM and Closing Date for Director Nominations 25 Sep 2026 1:46PM $0.425 $0.400 fallen by 5.88%
$92 Corporate Presentation September 2026 23 Sep 2026 9:26AM $0.420 $0.400 fallen by 4.76%
$92 Alterity Therapeutics to Present at ASX SMIDcaps Conference 18 Sep 2026 9:36AM $0.420 $0.400 fallen by 4.76%
$92 Application for quotation of securities - ATH 16 Sep 2026 12:36PM $0.430 $0.400 fallen by 6.98%
$92 Cleansing Notice Under Section 708A 8 Sep 2026 11:59AM $0.485 $0.400 fallen by 17.53%
$92 Application for quotation of securities - ATH 8 Sep 2026 11:41AM $0.495 $0.400 fallen by 19.19%
$92 Alterity to Present at Cantor Global Healthcare Conference 3 Sep 2026 9:26AM $0.520 $0.400 fallen by 23.08%
$92 Change of Director's Interest Notice - Stamler 2 Sep 2026 12:03PM $0.505 $0.400 fallen by 20.79%
$92 Change of Director's Interest Notice - Marks 2 Sep 2026 12:02PM $0.505 $0.400 fallen by 20.79%
$92 Application for quotation of securities - ATH 1 Sep 2026 2:54PM $0.500 $0.400 fallen by 20%
$92 Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC 31 Aug 2026 12:50PM $0.505 $0.400 fallen by 20.79%
$92 $4.2M Options Underwriting Agreement Executed 31 Aug 2026 9:51AM $0.520 $0.400 fallen by 23.08%
$92 Application for quotation of securities - ATH 28 Aug 2026 6:54PM $0.520 $0.400 fallen by 23.08%
$92 Corporate Governance Statement 28 Aug 2026 3:34PM $0.510 $0.400 fallen by 21.57%
$92 Appendix 4G 28 Aug 2026 3:33PM $0.510 $0.400 fallen by 21.57%
$92 Appendix 4E and 2026 Annual Report 28 Aug 2026 3:33PM $0.510 $0.400 fallen by 21.57%
$92 Application for quotation of securities - ATH 21 Aug 2026 2:24PM $0.485 $0.400 fallen by 17.53%
$92 Disclosure Under Takeovers Panel GN 20 17 Aug 2026 2:52PM $0.540 $0.400 fallen by 25.93%
$92 Application for quotation of securities - ATH 14 Aug 2026 4:08PM $0.520 $0.400 fallen by 23.08%
$92 Granted New U.S. Composition of Matter Patent for ATH434 12 Aug 2026 8:36AM $0.540 $0.400 fallen by 25.93%
$92 Application for quotation of securities - ATH 10 Aug 2026 6:01PM $0.535 $0.400 fallen by 25.23%
$92 Alterity to Present at Canaccord Genuity Growth Conference 6 Aug 2026 10:05AM $0.565 $0.400 fallen by 29.20%
$92 Application for quotation of securities - ATH 3 Aug 2026 4:22PM $0.590 $0.400 fallen by 32.20%
$92 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 10:00AM $0.510 $0.400 fallen by 21.57%
$92 Upcoming Expiry of ATHO Listed Options 29 Jul 2026 9:01AM $0.530 $0.400 fallen by 24.53%

1 - 25 of 575 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.